Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003 2004 and 2004 2005 influenza seasons

Pediatrics

Volumn 122, Issue 5, 2008, Pages 911-919

  Eisenberg, Katherine W ^a   Szilagyi, Peter G ^a   Fairbrother, Gerry ^c   Griffin, Marie R ^d   Staat, Mary ^c   Shone, Laura P ^a,b   Weinberg, Geoffrey A ^a   Hall, Caroline B ^a   Poehling, Katherine A ^e   Edwards, Kathryn M ^d   Lofthus, Geraldine ^a   Fisher, Susan G ^a   Bridges, Carolyn B ^f   Iwane, Marika K ^f  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e WAKE FOREST BAPTIST HEALTH   (United States)

^f NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Children; Influenza; Laboratory Confirmed; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; CHILD; CHILD HOSPITALIZATION; CONTROLLED STUDY; DRUG EFFICACY; EMERGENCY WARD; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INSURANCE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEASONAL VARIATION; SEX RATIO; STATISTICAL ANALYSIS; THROAT CULTURE; UNITED STATES; VIRUS CULTURE; ADOLESCENT; ADULT; CLINICAL TRIAL; COMORBIDITY; MIDDLE AGED; MULTICENTER STUDY; STATISTICAL MODEL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; COMORBIDITY; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 58149157486     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-3304     Document Type: Article

References (28)

1. Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355(1):31-40
2. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342(4):225-231
3. Coffin SE, Zaoutis TE, Rosenquist ABW, et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics. 2007; 119(4):740-748
4. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342(4):232-239
5. Neuzil KM, Zhu Y, Griffin MR, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis. 2002;185(2):147-152
6. Iwane MK, Edwards KM, Szilagyi PG, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics. 2004;113(6):1758-1764
7. Bridges CB, Harper SA, Fukuda K, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2003; 52(RR-8):1-34
8. Harper SA, Fukuda K, Uyeki TM, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004; 53(RR-6):1-40
9. Advisory Committee on Immunization Practices, Smith NM, Bresee JS, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-10):1-42
10. Shuler CM, Iwamoto M, Bridges CB, et al. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004. Pediatrics. 2007;119(3). Available at: www.pediatrics.org/cgi/content/full/119/3/e587
11. Ritzwoller DP, Bridges CB, Shetterly S, Yamasaki K, Kolczak M, France EK. Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics. 2005;116(1):153-159
12. Allison MA, Daley MF, Crane LA, et al. Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season. J Pediatr. 2006;149(6):755-762
13. Hoberman A, Greenberg DP, Paradise JL, et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA. 2003; 290(12):1608-1616
14. Zangwill KM, Belshe RB. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J. 2004;23(3):189 -197
15. Halloran ME, Longini IM Jr, Gaglani MJ, et al. Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. Am J Epidemiol. 2003;158(4):305-311
16. Frank AL, Taber LH, Wells CR, Wells JM, Glezen WP, Paredes A. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis. 1981;144(5):433-441
17. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB, Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005;54(RR-8):1-40
18. Erdman DD, Weinberg GA, Edwards KM, et al. GeneScan reverse transcription-PCR assay for detection of six common respiratory viruses in young children hospitalized with acute respiratory illness. J Clin Microbiol. 2003;41(9):4298-4303
19. Weinberg GA, Erdman DD, Edwards KM, et al. Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory infections in children. J Infect Dis. 2004;189(4):706-710
20. Kroger AT, Atkinson WL, Marcuse EK, Pickering LK, Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-15):1-48
21. Fiore AE, Shay DK, Haber P, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep. 2007;56(RR-6):1-54
22. Dupont WD, Plummer WD. PS power and sample size program available for free on the Internet. Control Clin Trials. 2007;18(3):274
23. Centers for Disease Control and Prevention. Update: influenza activity: United States and worldwide, 2003-04 season, and composition of the 2004-05 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2004;53(25):547-552
24. Centers for Disease Control and Prevention. Update: influenza activity: United States and worldwide, 2004-05 season. MMWR Morb Mortal Wkly Rep. 2005;54(25):631-634
25. Piedra P, Gaglani M, Kozinetz C, et al. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics. 2007;120(3). Available at: www.pediatrics.org/cgi/content/ full/120/3/e553
26. Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Pediatrics. 2006;118(3). Available at: www.pediatrics.org/cgi/ content/full/118/3/e579
27. Ohmit S, Victor J, Rotthoff J, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med. 2006;355(24):2513-2522
28. Lewis EN, Griffin MR, Szilagyi PG, Zhu Y, Edwards KM, Poehling KA. Childhood influenza: number needed to vaccinate to prevent 1 hospitalization or outpatient visit. Pediatrics. 2007;120(3):467-472